Selected publications
-
Improved outcomes after autologous hematopoietic cell transplantation for light chain amyloidosis: A center for international blood and marrow transplant research study.
Journal of Clinical Oncology.
2015
Academic Article
GET IT
Times cited: 85 -
Effect of postremission therapy before reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia in first complete remission.
Biology of Blood and Marrow Transplantation.
2014
Academic Article
GET IT
Times cited: 17 -
Allotransplantation for Patients Age ≥40 Years with Non-Hodgkin Lymphoma: Encouraging Progression-Free Survival.
Biology of Blood and Marrow Transplantation.
2014
Academic Article
GET IT
Times cited: 23 -
Younger adults with acute myeloid leukemia in remission for ≥3 years have a high likelihood of cure: The ECOG experience in over 1200 patients.
Leukemia Research.
2014
Academic Article
GET IT
Times cited: 3 -
Outcome of Lower-Intensity Allogeneic Transplantation in Non-Hodgkin Lymphoma after Autologous Transplantation Failure.
Biology of Blood and Marrow Transplantation.
2012
Academic Article
GET IT
Times cited: 19 -
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.
New England Journal of Medicine.
2012
Academic Article
GET IT
Times cited: 1081 -
Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis.
Blood.
2010
Academic Article
GET IT
Times cited: 124 -
A Comparison of HLA-Identical Sibling Allogeneic versus Autologous Transplantation for Diffuse Large B Cell Lymphoma: A Report from the CIBMTR.
Biology of Blood and Marrow Transplantation.
2010
Academic Article
GET IT
Times cited: 59 -
Impact of pre-transplant rituximab on survival after autologous hematopoietic stem cell transplantation for diffuse large B cell lymphoma.
Biology of Blood and Marrow Transplantation.
2009
Academic Article
GET IT
Times cited: 44 -
Clinical and Ultrasonic Evaluation of Spleen Size during Peripheral Blood Progenitor Cell Mobilization by Filgrastim: Results of an Open-Label Trial in Normal Donors.
Biology of Blood and Marrow Transplantation.
2009
Academic Article
GET IT
Times cited: 15 -
Unrelated Donor Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma: Long-Term Outcomes.
Biology of Blood and Marrow Transplantation.
2009
Academic Article
GET IT
Times cited: 27 -
Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma.
Biology of Blood and Marrow Transplantation.
2009
Academic Article
GET IT
Times cited: 78 -
Influence of Age and Histology on Outcome in Adult Non-Hodgkin Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation (HCT): A Report from The Center For International Blood & Marrow Transplant Research (CIBMTR).
Biology of Blood and Marrow Transplantation.
2008
Academic Article
GET IT
Times cited: 27 -
Second Autologous Stem Cell Transplantation for Relapsed Lymphoma after a Prior Autologous Transplant.
Biology of Blood and Marrow Transplantation.
2008
Academic Article
GET IT
Times cited: 43 -
Effect of Body Mass Index on Mortality of Patients with Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation.
Biology of Blood and Marrow Transplantation.
2006
Academic Article
GET IT
Times cited: 59 -
Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.
New England Journal of Medicine.
2002
Academic Article
GET IT
Times cited: 860 -
Autotransplants for Hodgkin's disease in patients never achieving remission: A report from the autologous blood and marrow transplant registry.
Journal of Clinical Oncology.
1999
Academic Article
GET IT
Times cited: 171